| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 09/14/2006 | US20060205676 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one |
| 09/14/2006 | US20060204587 Use of film coating as taste-masking coating of oral dosage forms |
| 09/14/2006 | CA2600475A1 Heteroarylsulfonyl stilbenes as 5-ht2a antagonists |
| 09/14/2006 | CA2599974A1 Pyridine-2-carboxamide derivatives as mglur5 antagonists |
| 09/13/2006 | EP1700845A1 Insecticidal anthranilamides |
| 09/13/2006 | EP1700844A1 Phthalic acid diamide derivatives, agricultural and horticultural insecticides and a method for application of the insecticides |
| 09/13/2006 | EP1699783A1 Opioid receptor antagonists |
| 09/13/2006 | EP1699766A1 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 09/13/2006 | EP1699763A1 3-trifluoromethyl picolinic acid anilides, and use thereof as fungicides |
| 09/13/2006 | EP1699752A1 (hetero)cyclyl carboxanilides for controlling harmful fungi |
| 09/13/2006 | EP1613326B1 (3-{3-'(2,4-bis-trifluormethyl-benzyl)-(5-ethyl-pyrimidin-2-yl)-amino]-propoxy}-phenyl)-acetic acid and related compounds as modulators of ppars and methods of treating metabolic disorders |
| 09/13/2006 | EP1597232B1 Novel crystalline modification of the anhydrate of boscalid |
| 09/13/2006 | EP1412364B1 Platelet adp receptor inhibitors |
| 09/13/2006 | EP1406869B1 Taxol enhancer compounds |
| 09/13/2006 | EP1097925B1 Novel benzoic acid derivatives and processes for the preparation thereof |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 09/13/2006 | CN1833470A Compound, charge transporting material and organic electroluminescent element |
| 09/13/2006 | CN1832975A New catalysts for selective isocyanate dimerization |
| 09/13/2006 | CN1832945A Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 09/13/2006 | CN1832935A Therapeutic agents useful for treating pain |
| 09/13/2006 | CN1832923A Method for the manufacture of cyanopyridines and catalysts suitable therefor |
| 09/13/2006 | CN1832922A Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides |
| 09/13/2006 | CN1832761A Thiotungstate analogues and uses thereof |
| 09/13/2006 | CN1830963A Method for synthesizing 2,3-difluoro-5-chloropyridine |
| 09/13/2006 | CN1830962A Derivatives of 2,6-dipyridylene cyclohexanone, and its application in preparing antibacterial medicine |
| 09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
| 09/13/2006 | CN1274655C Novel 3-aryl-2,5-dihydroxy-1,4-benzoquinone derivatives, their preparation method and pharmaceutical compositions containing same |
| 09/12/2006 | US7105707 By reacting an aryl nitrile with an alkynylzinc compound, a bis-alkynylzinc compound, or an alkynylmagnesium compound, in the presence of a nickel/phosphine catalyst. |
| 09/12/2006 | US7105701 Multibinding compounds for agonists for phenolic derivatives for adrenergic receptors with carriers |
| 09/12/2006 | US7105673 Cardioprotective phosphonates and malonates |
| 09/12/2006 | US7105672 Cyclometallated catalysts |
| 09/12/2006 | US7105671 2-Substituted phenyl,3-polar ring,N-heroaromatic propion-amides, e.g., 1-(2-(3,4-Dichlorophenyl)-3-(tetrahydro-furan-2-yl)-propionyl)-3- methylurea; antidiabetic agents; increase the flux of glucose metabolism in beta-cells and hepatocytes |
| 09/12/2006 | US7105567 Such as N-benzyl-N'-(2,6-dimethylphenyl)-N-(4-octylphenyl)urea for treating autoimmune diseases, sepsis, adult respiratory distress syndrome, chronic obstructive pulmonary disease, allergies/asthma, atherosclerosis, and brain disorders |
| 09/12/2006 | US7105564 7-(3-{[5-(Pyrrole-1-sulfonyl)-thiophene-2-carbonyl]-amino}-bicyclo[2.2.1]hept-2-yl)-hept-5-enoic acid; thromboxane A2 receptor and a prostaglandin D2 receptor; for all of eosinophilic infiltration, advance of respiratory anaphylaxis and respiratory contraction |
| 09/12/2006 | US7105559 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 09/12/2006 | US7105549 Aryl substituted pyridines and the use thereof |
| 09/12/2006 | US7105546 Useful for treating or preventing neuronal damage associated with neurological diseases |
| 09/12/2006 | US7105539 such as N-[1-Carboxy-2-(1H-indol-3-yl)-ethyl]-3-(2-mercapto-acetylamino)-succinamic acid; endopeptidase (Phex/pex) inhibitors; for promoting generation of bone mass and treating or preventing diseases or conditions associated with phosphate metabolism defect; drug screening |
| 09/12/2006 | US7105508 Integrin receptors antagonists |
| 09/12/2006 | CA2235986C Inhibitors of protein isoprenyl transferases |
| 09/12/2006 | CA2140929C Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 09/08/2006 | WO2006093339A1 Use of cinnamoyl compound |
| 09/08/2006 | WO2006093336A1 Use of cinnamoyl compound |
| 09/08/2006 | WO2006093124A1 Free radical scavenger containing semicarbazide derivative |
| 09/08/2006 | WO2006092430A1 Selective inhibitors of human corticosteroid synthases |
| 09/08/2006 | WO2006092204A1 Derivatives of aminobutanoic acid inhibiting cpt |
| 09/08/2006 | WO2006039221A3 Cyclopropyl piperidine glycine transporter inhibitors |
| 09/08/2006 | WO2005086700A3 Hiv integrase inhibitors |
| 09/08/2006 | CA2600287A1 Use of cinnamoyl compound |
| 09/08/2006 | CA2599165A1 Derivatives of aminobutanoic acid inhibiting cpt |
| 09/07/2006 | US20060199965 Process for the preparation of nicotinaldehydes |
| 09/07/2006 | US20060199964 preparation of 6-haloalkyl-3-nicotinic acid esters and also to novel enamine intermediates |
| 09/07/2006 | US20060199856 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid |
| 09/07/2006 | US20060199847 Stable ammonium salts of alpha-liponic acid, the production thereof and the use of the same |
| 09/07/2006 | US20060199844 Inhibitors of raf-kinase; Hyperproliferative disorders |
| 09/07/2006 | US20060199826 Cyclopropane compounds and pharmaceutical use thereof |
| 09/07/2006 | US20060199822 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 09/07/2006 | US20060199820 e.g. N1-hydroxy-N2-[(4-phenoxyphenyl)sulfonyl]-D-argininamide; metallopeptidase inhibitor; antiinflammation, anticarcinogenic, antidiabetic agent; angiogenesis inhibitor; atherosclerosis, stroke, ulcer, infertility, scleroderma, endometriosis, mesothelioma |
| 09/07/2006 | US20060199802 Pyridyl derivatives and their use as therapeutic agents |
| 09/07/2006 | DE102005009705A1 Use of naphthalene derivatives for the treatment of hyperaldosteronism, heart failure, myocardial fibrosis, hypercortisolism and diabetes mellitus |
| 09/06/2006 | EP1698620A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 09/06/2006 | EP1698618A1 Benzamide derivative |
| 09/06/2006 | EP1698606A1 Fluorinating agent and method for producing fluorine-containing compound using same |
| 09/06/2006 | EP1697344A2 Hiv protease inhibiting compounds |
| 09/06/2006 | EP1697339A1 3-(4-benzyloxyphenyl)propanoic acid derivatives |
| 09/06/2006 | EP1697336A2 Aroylfuranes and aroylthiophenes suitable for the treatment of cancer |
| 09/06/2006 | EP1697325A1 Benzoyl amino pyridyl carboxylic acid derivatives useful as glucokinase (glk) activators |
| 09/06/2006 | EP1697324A1 Benzoyl amino pyridyl carboxylic acid derivatives useful as glucokinase (glk) activators |
| 09/06/2006 | EP1697312A2 Hydroxamic acid esters and pharmaceutical use thereof |
| 09/06/2006 | EP1697309A2 Benzoyl-substituted phenylalanine amides |
| 09/06/2006 | EP1697308A2 Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer s disease |
| 09/06/2006 | EP1697307A1 Opioid receptor antagonists |
| 09/06/2006 | EP1697305A1 Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-ht1f agonists |
| 09/06/2006 | EP1697304A1 Peroxisome proliferator activated receptor modulators |
| 09/06/2006 | EP1697301A2 Aminoalcohol derivatives |
| 09/06/2006 | EP1696916A1 Use of metabotropic glutamate receptor 5 (mglur5) antagonists for the treatment of gastrointestinal disorders |
| 09/06/2006 | EP1696915A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 09/06/2006 | EP1696898A2 Zn 24 -chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors |
| 09/06/2006 | EP1572656A4 Compounds useful as pesticides |
| 09/06/2006 | EP1517894B1 N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin antagonists and/or serotonin reuptake inhibitors |
| 09/06/2006 | EP1423357B1 Urea derivatives with antiproteolytic activity |
| 09/06/2006 | EP1303308B1 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders |
| 09/06/2006 | CN1829692A Novel pyrithione complex compound, process for producing the same and use thereof |
| 09/06/2006 | CN1829691A Pyridyl derivatives and their use as therapeutic agents |
| 09/06/2006 | CN1829690A Pyridyl derivatives and their use as therapeutic agents |
| 09/06/2006 | CN1273444C Dipeptide nitriles |
| 09/06/2006 | CN1273442C Process for prepn. of acyl phenylalanines |
| 09/06/2006 | CN1273128C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides |
| 09/05/2006 | US7102024 Functional biopolymer modification reagents and uses thereof |
| 09/05/2006 | US7102006 Preparation of metal complexes |
| 09/05/2006 | US7101915 P-terphenyl compounds |
| 09/05/2006 | US7101912 when co-administered with levodopa in the colon of a patient is taken up at a much higher bioavailability than levodopa alone; treating Parkinson's disease or hypertension; dosage forms; sustained release; oral administration |
| 09/05/2006 | US7101911 Bis(substituted propynyl)-substituted benzenes, pyridines, pyrimidines, pyrazines, pyridines, furans and pyrroles; e.g., 3,5-bis-(3-(4-aminomethylbenzylaminocarbonyloxy)prop-1-ynyl)--1 -hydroxymethylbenzene |
| 09/05/2006 | US7101910 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 09/05/2006 | US7101907 Topical administration of statins for treatment of bone disorders |
| 09/05/2006 | US7101900 Benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides |
| 09/05/2006 | US7101896 Pharmaceutical compositions and methods for use |
| 09/05/2006 | US7101895 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 09/05/2006 | US7101868 A 2-(((4-fluorophenyl)methyl)amino)-3-pyridinecarboxamide derivatives for treating cancer, angiogenesis, tumor |
| 09/04/2006 | CA2539710A1 Zwitterionic chromophores and macromolecules containing such chromophores |